AbCellera to Present at Upcoming Investor Conferences in September
30 8월 2024 - 5:05AM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will be presenting at the following investor
conferences:
- Wells Fargo Healthcare Conference on Thursday, September 5,
2024, at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time)
- Cantor Global Healthcare Conference on Tuesday, September 17,
2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)
Live audio webcasts of each presentation may be accessed through
links that will be posted on AbCellera's Investor Relations
website. Replays of each webcast will be available through the same
links following the presentations.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody
medicines for indications across therapeutic areas, including
cancer, metabolic and endocrine conditions, and autoimmune
disorders. AbCellera’s engine integrates technology, data science,
infrastructure, and interdisciplinary teams to solve the most
challenging antibody discovery problems. AbCellera is focused on
advancing an internal pipeline of first-in-class and best-in-class
programs and collaborating on innovative drug development programs
with partners. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240829861441/en/
Inquiries
Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com,
+1(604)559-9005 Investor Relations: Melanie Solomon;
ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
AbCellera Biologics (NASDAQ:ABCL)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
